Skip to content
MedsAcross

Brand family

Jaypirca

Pirtobrutinib · Eli Lilly
United States
Presentations
2
Markets
1

Jaypirca is a brand of Pirtobrutinib marketed by Eli Lilly, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Pirtobrutinib
Brand owner
Eli Lilly
Registered in
United States
Strengths and forms
100 mg tablet, 50 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Jaypirca 100 mg tabletOralEli LillyUS FDAAvailable on request
Jaypirca 50 mg tabletOralEli LillyUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Jaypirca

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.